Xeris Pharmaceuticals, Inc. (XERS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-62,255
-62,255
-94,660
-122,725
-91,140
Depreciation & amortisation
13,160
13,160
12,668
1,879
1,467
Deferred income taxes
-1,249
-1,249
-1,424
0
-
Stock-based compensation
10,716
10,716
12,160
11,381
8,273
Change in working capital
-6,294
-6,294
-35,150
11,854
-2,798
Accounts receivable
-8,367
-8,367
-13,374
-6,237
-2,182
Inventory
-14,804
-14,804
-7,465
-7,418
-5,143
Accounts payable
6,959
6,959
-4,318
5,527
-2,486
Other working capital
-49,286
-49,286
-103,415
-96,620
-80,935
Other non-cash items
-2,995
-2,995
3,632
961
3,104
Net cash provided by operating activities
-47,023
-47,023
-102,891
-95,535
-80,558
Cash flows from investing activities
Investments in property, plant and equipment
-2,263
-2,263
-524
-1,085
-377
Purchases of investments
-43,741
-43,741
0
-43,020
-101,773
Sales/maturities of investments
40,000
40,000
34,985
103,600
74,745
Net cash used for investing activities
-6,004
-6,004
34,461
97,964
-27,405
Cash flows from financing activities
Debt repayment
0
0
-43,496
0
-25,089
Common stock issued
0
0
30,000
27,000
65,891
Common stock repurchased
-1,009
-1,009
-468
-534
-63
Other financing activities
-1,185
-1,185
-5,613
-54
-10,318
Net cash used provided by (used for) financing activities
-1,613
-1,613
127,473
27,247
126,064
Net change in cash
-54,640
-54,640
59,043
29,673
18,079
Cash at beginning of period
126,314
126,314
67,271
37,598
19,519
Cash at end of period
71,674
71,674
126,314
67,271
37,598
Free cash flow
Operating cash flow
-47,023
-47,023
-102,891
-95,535
-80,558
Capital expenditure
-2,263
-2,263
-524
-1,085
-377
Free cash flow
-49,286
-49,286
-103,415
-96,620
-80,935
© 2024 Yahoo. All rights reserved.